Zolpidem in Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder, characterized by motor symptoms, postural instability, personality changes, and cognitive impairment. There is no effective treatment for this disorder. Reduced neurotransmission of GABA in the striatum and globus pall...
Main Author: | Sandip K. Dash |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Neurological Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/250865 |
Similar Items
-
Trial of Zolpidem, Eszopiclone, and Other GABA Agonists in a Patient with Progressive Supranuclear Palsy
by: Andrew Young Chang, et al.
Published: (2014-01-01) -
Genetics of Progressive Supranuclear Palsy
by: Sun Young Im, et al.
Published: (2015-09-01) -
Research on progressive supranuclear palsy
by: Yiming LIU, et al.
Published: (2011-02-01) -
Affective symptoms in progressive supranuclear palsy
by: K S Shaji, et al.
Published: (2014-01-01) -
Understanding fatigue in progressive supranuclear palsy
by: Jong Hyeon Ahn, et al.
Published: (2021-08-01)